Path
Clinical trials sponsored by Path, explained in plain language.
-
New polio vaccine trial aims to protect the youngest
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new oral polio vaccine (nOPV3) in healthy young children, infants, and newborns to see if it is safe and triggers a strong immune response. About 1,500 participants in Panama will receive either the new vaccine or an existing one. The goal is to find a safer an…
Phase: PHASE2 • Sponsor: PATH • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 10:41 UTC
-
New polio vaccine trial aims to protect the youngest
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new oral polio vaccine (nOPV1) in over 2,200 healthy children, infants, and newborns in Bangladesh. The goal is to see if it is safe and triggers a strong immune response compared to the current vaccine. Participants will receive up to three doses and be monito…
Phase: PHASE2 • Sponsor: PATH • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 10:27 UTC
-
Could two polio shots at once protect more kids?
⭐️ VACCINE ⭐️ Recruiting nowThis study tests whether giving two new oral polio vaccines together is safe and works as well as giving them separately in healthy 16-week-old infants. About 675 babies in Panama will receive either the combined or single vaccines. The goal is to see if the combined approach can…
Phase: PHASE2 • Sponsor: PATH • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:53 UTC